+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Quanterix  - logo

Quanterix Corporation develops ultra-sensitive detection systems for use in research and in-vitro diagnostics. The company offers automated immunoassay technology for detection and quantification of biomarkers in in-vitro and companion diagnostics and blood screening. Its products are used in life science, oncology, and neurology research in the United States. Quanterix Corporation was formerly known as Digital Genomics Inc. and changed its name to Quanterix Corporation in August 2007. The company is based in Lexington, Massachusetts.

From
From
Neurological Biomarkers Market 2024-2028 - Product Thumbnail Image

Neurological Biomarkers Market 2024-2028

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Neurological Biomarkers Market - Global Forecast 2025-2032 - Product Thumbnail Image

Neurological Biomarkers Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 188 Pages
  • Global
From
Neurological Biomarkers Market Report 2025 - Product Thumbnail Image

Neurological Biomarkers Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Custom Assay Development Market - Global Forecast to 2030 - Product Thumbnail Image

Custom Assay Development Market - Global Forecast to 2030

  • Report
  • August 2025
  • 181 Pages
  • Global
From
From
From
Brain Biomarkers Market - Global Forecast 2025-2032 - Product Thumbnail Image

Brain Biomarkers Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 194 Pages
  • Global
From
From
From
From
Clinical Biomarkers Market Report 2025 - Product Thumbnail Image

Clinical Biomarkers Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Loading Indicator